Related Experiment Video
Updated: Sep 6, 2025
10:12
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
2.9K
Overcoming the Limitations of Stem Cell-Derived Beta Cells
Mariana V Karimova1, Inessa G Gvazava1, Ekaterina A Vorotelyak1,2
1Koltzov Institute of Developmental Biology of Russian Academy of Sciences, 119334 Moscow, Russia.
Biomolecules
|June 24, 2022
Summary
Researchers are developing stem cell-derived beta cells to treat type 1 and type 2 diabetes. Current methods yield functional beta-like cells, but further maturation is needed for effective therapy.
Area of Science:
- Endocrinology and Regenerative Medicine
- Stem Cell Biology and Diabetes Research
Background:
- Current type 1 and type 2 diabetes treatments, including insulin injections and islet transplantation, have significant limitations.
- The development of functional, stem cell-derived beta cells offers a promising alternative for unlimited insulin production.
Purpose of the Study:
- To review current protocols for generating stem cell-derived beta cells.
- To identify strategies for improving the functional maturation of these cells.
- To explore the potential of islet organoids for diabetes therapy.
Main Methods:
- Review of existing literature on stem cell-derived beta cell generation protocols.
- Analysis of molecular pathways, epigenetic modifications, intracellular components, and microenvironmental factors influencing beta cell maturation.
- Examination of islet organoid formation, encapsulation, and transplantation techniques.
Main Results:
- Protocols exist to generate beta-like cells exhibiting glucose-stimulated insulin secretion.
- Stem cell-derived beta cells currently lack the full functional maturation of native beta cells.
- Various factors including molecular pathways and microenvironment can be leveraged to enhance maturation.
Conclusions:
- Stem cell-derived beta cells hold significant promise for diabetes treatment but require further functional maturation.
- Optimizing protocols by targeting specific pathways and microenvironmental cues is crucial.
- Islet organoids represent a viable future direction for transplantation-based diabetes therapies.
Related Concept Videos
01:23Tissue Renewal without Stem Cells
1.8K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.8K
01:17Stem Cell Culture
5.3K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.3K
01:06Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:21EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
00:58Embryonic Stem Cells
29.0K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
29.0K